Telehealth Co. Swaps In Gordon Rees In Novo's GLP-1 Fight
By Ben Adlin · March 5, 2026, 10:11 PM EST
A telehealth platform facing allegations from Novo Nordisk that it falsely advertised Ozempic alternatives has picked new counsel in the dispute, withdrawing attorneys from Foley & Lardner LLP and Miller Nash...
To view the full article, register now.